雀巢“预防性召回”奶粉事件是怎么回事？

Core Viewpoint - The article discusses the recall of infant formula by Nestlé in 31 countries due to potential contamination with Bacillus cereus, prompting regulatory scrutiny on Jia Bi You Biotechnology (Wuhan) Co., Ltd. for its involvement in the supply chain [1][3][6]. Group 1: Regulatory Actions - The Shanghai Stock Exchange issued a regulatory letter to Jia Bi You, urging the company to respond promptly and fulfill its information disclosure obligations [1][2]. - The National Market Supervision Administration emphasized the importance of Nestlé (China) Ltd. adhering to corporate responsibility in recalling affected products [6]. Group 2: Product Recall Details - Nestlé announced a voluntary recall of specific batches of infant formula, including products like "力多精" and "惠氏膳儿加," due to quality issues with a supplier's raw materials [3][5]. - The recall affects 30 batches of products sold in mainland China and 41 batches sold through cross-border e-commerce channels [3][5]. Group 3: Supplier and Quality Control - The specific supplier of the problematic arachidonic acid (ARA) used in the affected products has not been disclosed, although major producers include Jia Bi You, DSM, and Runke [6][11]. - Both DSM and Runke have publicly stated that they are not responsible for the contaminated ARA, asserting their products meet strict quality control standards [8][10]. Group 4: Industry Standards and Safety - There is a debate regarding the absence of specific limits for Bacillus cereus in China's infant formula standards, with experts arguing that total bacterial counts are regulated instead [11][12]. - The management of Bacillus cereus is crucial, as it can produce toxins when proliferating, highlighting the need for stringent quality control measures throughout the supply chain [12].